196 related articles for article (PubMed ID: 31582723)
1. Genetic risk for Alzheimer's dementia predicts motor deficits through multi-omic systems in older adults.
Tasaki S; Gaiteri C; Petyuk VA; Blizinsky KD; De Jager PL; Buchman AS; Bennett DA
Transl Psychiatry; 2019 Oct; 9(1):241. PubMed ID: 31582723
[TBL] [Abstract][Full Text] [Related]
2. The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia.
Tasaki S; Gaiteri C; Mostafavi S; De Jager PL; Bennett DA
Front Neurosci; 2018; 12():699. PubMed ID: 30349450
[TBL] [Abstract][Full Text] [Related]
3. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
4. Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting.
Euesden J; Gowrisankar S; Qu AX; Jean PS; Hughes AR; Pulford DJ
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32370229
[No Abstract] [Full Text] [Related]
5. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
[TBL] [Abstract][Full Text] [Related]
6. Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults.
Liebers DT; Pirooznia M; Seiffudin F; Musliner KL; Zandi PP; Goes FS
Schizophr Bull; 2016 Jul; 42(4):984-91. PubMed ID: 26873889
[TBL] [Abstract][Full Text] [Related]
7. Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal aging.
Kauppi K; Rönnlund M; Nordin Adolfsson A; Pudas S; Adolfsson R
Transl Psychiatry; 2020 Jul; 10(1):250. PubMed ID: 32709845
[TBL] [Abstract][Full Text] [Related]
8. The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk.
Fan J; Tao W; Li X; Li H; Zhang J; Wei D; Chen Y; Zhang Z
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866553
[TBL] [Abstract][Full Text] [Related]
9. Genetic Stratification to Identify Risk Groups for Alzheimer's Disease.
Marioni RE; Campbell A; Hagenaars SP; Nagy R; Amador C; Hayward C; Porteous DJ; Visscher PM; Deary IJ
J Alzheimers Dis; 2017; 57(1):275-283. PubMed ID: 28222519
[TBL] [Abstract][Full Text] [Related]
10. Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition.
Leonenko G; Shoai M; Bellou E; Sims R; Williams J; Hardy J; Escott-Price V;
Ann Neurol; 2019 Sep; 86(3):427-435. PubMed ID: 31199530
[TBL] [Abstract][Full Text] [Related]
11. Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain.
Felsky D; Patrick E; Schneider JA; Mostafavi S; Gaiteri C; Patsopoulos N; Bennett DA; De Jager PL
Mol Neurodegener; 2018 Jul; 13(1):38. PubMed ID: 30041668
[TBL] [Abstract][Full Text] [Related]
12. Dissociable influences of
Ge T; Sabuncu MR; Smoller JW; Sperling RA; Mormino EC;
Neurology; 2018 May; 90(18):e1605-e1612. PubMed ID: 29592889
[TBL] [Abstract][Full Text] [Related]
13. Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
Liu H; Lutz M; Luo S;
J Alzheimers Dis; 2021; 84(3):1323-1335. PubMed ID: 34657885
[TBL] [Abstract][Full Text] [Related]
14. Considering the APOE locus in Alzheimer's disease polygenic scores in the Health and Retirement Study: a longitudinal panel study.
Ware EB; Faul JD; Mitchell CM; Bakulski KM
BMC Med Genomics; 2020 Nov; 13(1):164. PubMed ID: 33143703
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
[TBL] [Abstract][Full Text] [Related]
16. A Non-APOE Polygenic Risk Score for Alzheimer's Disease Is Associated With Cerebrospinal Fluid Neurofilament Light in a Representative Sample of Cognitively Unimpaired 70-Year Olds.
Skoog I; Kern S; Najar J; Guerreiro R; Bras J; Waern M; Zetterberg H; Blennow K; Zettergren A
J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):983-990. PubMed ID: 33512503
[TBL] [Abstract][Full Text] [Related]
17. The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease.
Femminella GD; Harold D; Scott J; Williams J; Edison P;
J Alzheimers Dis; 2021; 79(1):127-139. PubMed ID: 33216025
[TBL] [Abstract][Full Text] [Related]
18. From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.
Harrison JR; Mistry S; Muskett N; Escott-Price V
J Alzheimers Dis; 2020; 74(4):1271-1283. PubMed ID: 32250305
[TBL] [Abstract][Full Text] [Related]
19. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
[TBL] [Abstract][Full Text] [Related]
20. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
